Association of Prostate-Specific Antigen Velocity With Clinical Progression Among African American and Non-Hispanic White Men Treated for Low-Risk Prostate Cancer With Active Surveillance

IMPORTANCE: The association of prostate-specific antigen velocity (PSAV) with clinical progression in patients with localized prostate cancer managed with active surveillance remains unclear and, to our knowledge, has not been studied in African American patients. OBJECTIVES: To test the hypothesis...

Descripción completa

Detalles Bibliográficos
Autores principales: Nelson, Tyler J., Javier-DesLoges, Juan, Deka, Rishi, Courtney, P. Travis, Nalawade, Vinit, Mell, Loren, Murphy, James, Parsons, J. Kellogg, Rose, Brent S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129822/
https://www.ncbi.nlm.nih.gov/pubmed/33999164
http://dx.doi.org/10.1001/jamanetworkopen.2021.9452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129822/
https://www.ncbi.nlm.nih.gov/pubmed/33999164
http://dx.doi.org/10.1001/jamanetworkopen.2021.9452

Ejemplares similares